Soluble Fiber Supplementation and Serum Lipid Profile: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials Publisher Pubmed



Ghavami A¹ ; Ziaei R² ; Talebi S³ ; Barghchi H⁴ ; Nattagheshtivani E⁵ ; Moradi S⁶ ; Rahbarinejad P⁴ ; Mohammadi H³ ; Ghasemitehrani H⁷ ; Marx W⁸ ; Askari G² Show Affiliations
Source: Advances in Nutrition Published:2023

Abstract

To present a comprehensive synthesis of the effect of soluble fiber supplementation on blood lipid parameters in adults, a systematic search was undertaken in PubMed, Scopus, and ISI Web of Science of relevant articles published before November 2021. Randomized controlled trials (RCTs) evaluating the effects of soluble fibers on blood lipids in adults were included. We estimated the change in blood lipids for each 5 g/d increment in soluble fiber supplementation in each trial and then calculated the mean difference (MD) and 95% CI using a random-effects model. We estimated dose-dependent effects using a dose-response meta-analysis of differences in means. The risk of bias and certainty of the evidence was evaluated using the Cochrane risk of bias tool and the Grading Recommendations Assessment, Development, and Evaluation methodology, respectively. A total of 181 RCTs with 220 treatment arms (14,505 participants: 7348 cases and 7157 controls) were included. There was a significant reduction in LDL cholesterol (MD: −8.28 mg/dL, 95% CI: −11.38, −5.18), total cholesterol (TC) (MD: −10.82 mg/dL, 95% CI: −12.98, −8.67), TGs (MD: −5.55 mg/dL, 95% CI: −10.31, −0.79), and apolipoprotein B (Apo-B) (MD: −44.99 mg/L, 95% CI: −62.87, −27.12) after soluble fiber supplementation in the overall analysis. Each 5 g/d increase in soluble fiber supplementation had a significant reduction in TC (MD: −6.11 mg/dL, 95% CI: −7.61, −4.61) and LDL cholesterol (MD: −5.57 mg/dl, 95% CI: −7.44, −3.69). In a large meta-analysis of RCTs, results suggest that soluble fiber supplementation could contribute to the management of dyslipidemia and the reduction of cardiovascular disease risk. © 2023 The Author(s)